Nectero Therapeutics, a clinical-stage biotechnology company developing therapies for aneurysmal disease, released two-year outcomes data today from the company’s first-in-human (FIH) trial of their ...
Abdominal aortic aneurysm, a weakening and ballooning of the aorta, the largest blood vessel in the body, may result in a life-threatening rupture. In a small, preliminary study examining a potential ...
Researchers linked clonal hematopoiesis to faster progression of aortic aneurysms. They showed that osteoporosis drugs slowed ...
Using contrast enhanced ultrasound is an effective way of monitoring patients undergoing endovascular repair for abdominal aortic aneurysms without any noninvasive tests, a study published in the ...
NEW YORK (CBSNewYork)-- Abdominal aortic aneurysm is a life-threatening condition that affects more than 3 million Americans annually and can kill up to 90% of people who have it, but it's almost ...
PHILADELPHIA (CBS) --A new treatment for a silent killer that's usually found accidentally. 3 On Your Side Health Reporter Stephanie Stahl has more on a newly FDA approved device. Paul Bilella has a ...
Contrast-enhanced ultrasound is an effective, noninvasive method for monitoring patients who undergo endovascular repair for abdominal aortic aneurysms, according to a new study published in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results